drugset / Trial / NCT07592689
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RandomizedParallel-groupTriple-blindTreatment
Summary
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend
Timeline
- Start
- 2026-05-10
- Primary completion
- 2027-09
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DT120 | Unknown | 50 ug | Oral |
| Subject | DT120 | Unknown | 100 ug | Oral |